Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease

Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design

“…Additionally, the NNT of 11 demonstrates that BAM infusion was able to significantly prevent mortality from SARS‐CoV‐2 infection. These results are similar to or better than other preventive initiatives 15–19 …”

Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design

“…Additionally, the NNT of 11 demonstrates that BAM infusion was able to significantly prevent mortality from SARS‐CoV‐2 infection. These results are similar to or better than other preventive initiatives 15–19 …”

Effectiveness of pneumococcal vaccine in patients with chronic obstructive pulmonary disease (COPD)

“…Our study was at par with Walter JAE et al, who concluded that vaccination reduced the likelihood of a COPD exacerbation, and moderate-quality evidence suggests the benefits of pneumococcal vaccination in people with COPD. 10 So, this study shows that the protective efficacy of 23 serotype PPV in COPD patients is linked to five factorsage (<65yr), female sex, BMI (≤21kg/m 2 ), severity of disease (severe and very severe obstruction) and associated comorbidities as can be seen from the reduction exacerbation frequencies.…”

Optimizing quality of care in patients admitted with chronic obstructive pulmonary disease exacerbation

“…Utilization of inpatient AECOPD order sets have improved physician’s adherence to providing guideline- and evidence-based pharmacologic treatment, reduced in length of hospital stay, and decreased steroid exposure. 13–17 These results suggest that computerized guideline-based AECOPD order sets at admission can be a strategy to standardize the delivery of guideline-based treatment for AECOPD, and ultimately patient outcomes.…”

Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design

“…Additionally, the NNT of 11 demonstrates that BAM infusion was able to significantly prevent mortality from SARS‐CoV‐2 infection. These results are similar to or better than other preventive initiatives 15–19 …”

Effectiveness of pneumococcal vaccine in patients with chronic obstructive pulmonary disease (COPD)

“…Our study was at par with Walter JAE et al, who concluded that vaccination reduced the likelihood of a COPD exacerbation, and moderate-quality evidence suggests the benefits of pneumococcal vaccination in people with COPD. 10 So, this study shows that the protective efficacy of 23 serotype PPV in COPD patients is linked to five factorsage (<65yr), female sex, BMI (≤21kg/m 2 ), severity of disease (severe and very severe obstruction) and associated comorbidities as can be seen from the reduction exacerbation frequencies.…”

Optimizing quality of care in patients admitted with chronic obstructive pulmonary disease exacerbation

“…Utilization of inpatient AECOPD order sets have improved physician’s adherence to providing guideline- and evidence-based pharmacologic treatment, reduced in length of hospital stay, and decreased steroid exposure. 13–17 These results suggest that computerized guideline-based AECOPD order sets at admission can be a strategy to standardize the delivery of guideline-based treatment for AECOPD, and ultimately patient outcomes.…”

Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design

“…Additionally, the NNT of 11 demonstrates that BAM infusion was able to significantly prevent mortality from SARS‐CoV‐2 infection. These results are similar to or better than other preventive initiatives 15–19 …”

Effectiveness of pneumococcal vaccine in patients with chronic obstructive pulmonary disease (COPD)

“…Our study was at par with Walter JAE et al, who concluded that vaccination reduced the likelihood of a COPD exacerbation, and moderate-quality evidence suggests the benefits of pneumococcal vaccination in people with COPD. 10 So, this study shows that the protective efficacy of 23 serotype PPV in COPD patients is linked to five factorsage (<65yr), female sex, BMI (≤21kg/m 2 ), severity of disease (severe and very severe obstruction) and associated comorbidities as can be seen from the reduction exacerbation frequencies.…”

Optimizing quality of care in patients admitted with chronic obstructive pulmonary disease exacerbation

“…Utilization of inpatient AECOPD order sets have improved physician’s adherence to providing guideline- and evidence-based pharmacologic treatment, reduced in length of hospital stay, and decreased steroid exposure. 13–17 These results suggest that computerized guideline-based AECOPD order sets at admission can be a strategy to standardize the delivery of guideline-based treatment for AECOPD, and ultimately patient outcomes.…”